Fosfomycin versus ciprofloxacin for febrile neutropenia prophylaxis in high-risk haematological patients (FOVOCIP): a phase 3, open-label, multicentre, randomised, non-inferiority trial - ScienceDirect
#Fosfomycin did not demonstrate non-inferiority to #ciprofloxacin in the prevention of #febrileneutropenia in high-risk #haematologicalpatients. The higher incidence of Gram-negative bacteraemia discourages its use
https://www.sciencedirect.com/science/article/pii/S2666776226001109
One-year multicenter surveillance of #Fosfomycin resistance Enterobacterales:
The rise of FosA3-producing #Proteus mirabilis
https://davidojcius.blogspot.com/2026/03/one-year-multicenter-surveillance-of.html
Not that surprising, but there's also #fosfomycin #resistance spreading around the world. Here in #Salmonella
#AMR #microbiology #medicine #infectiousdiseases #MedMastodon
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00261-6/fulltext?dgcid=raven_jbs_aip_email
Cientounero
David Ojcius
Gabriele Pollara